Factor XIII in Major Burns Coagulation

V

Vall d'Hebron University Hospital (HUVH)

Status

Unknown

Conditions

Endothelial Dysfunction
Coagulation Disorder
Burns
Cicatrization
Factor XIII Deficiency

Treatments

Diagnostic Test: Coagulation tests

Study type

Observational

Funder types

Other

Identifiers

NCT03188913
PR(ATR)341/2016

Details and patient eligibility

About

Prospective observational study in which FXIII levels and coagulation tests and cicatrization are measured during the 30 days after the thermal trauma.

Full description

This is a prospective observational pilot study in which the levels of FXIII and coagulation, anticoagulation, fibrinolysis, endothelial tissue damage and cicatrization are at the arrival of the patient to hospital, 24 hours before the first surgical intervention, 24h After the first surgical intervention, at 7 days after the first intervention and at 30 days after the thermal trauma, in this moment the healing will also be evaluated. All burn patients who meet the proposed inclusion criteria will be included and entered into the Burn Unit of the Vall d'Hebron University Hospital from the start of the study until reaching a minimum of 20 cases or a temporary term of 2 years.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Burned patients with a burned body surface of 20% or more
  • Over 18 years of age

Exclusion criteria

  • ABSI (Abbreviated Burns Severity Index) greater than or equal to 12
  • Associated polytrauma
  • Coagulation deficit previously known
  • Treatment with anticoagulants
  • Electrocution burns
  • Admission into the unit after hour 6 after thermal trauma
  • The refusal of the patient, familiar or responsible to participate in the study

Trial contacts and locations

0

Loading...

Central trial contact

Patricia Guilabert, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems